RxDoctor Payments Data

Michael Moulton, MD

Nephrology · Springdale, ARNPI 1558397489

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,009 of the $1,392 with a category attached, or 72.5%. Vantive US Healthcare LLC accounts for 88.4% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $1,278, more than ten times the $13 reported in 2019.

$1,392in general payments, 2019–2025

Across 16 payments — averaging $86.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vantive US Healthcare LLC$1K
  • Baxter Healthcare$78
  • AstraZeneca$38
  • Boehringer Ingelheim$32
  • Artivion, Inc.$13

What the payments were for

  • Travel & lodging$1,00973%
  • Food & beverage$38327%

General payments by program year

19
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,392 in reported general payments places this provider in the 55th percentile of 85 nephrology providers in Arkansas.

See all nephrology providers in Arkansas

Medicare billing

Part B allowed, 2024
$228,952
Medicare patients
648
Services billed
1,663

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cinacalcet Hcl15$5,399
Potassium Citrate ErPotassium Citrate35$3,998
VascepaIcosapent Ethyl11$3,834
Torsemide134$1,565
Calcium Acetate19$1,313
Nifedipine ErNifedipine46$1,133
Gentamicin Sulfate28$1,019
Midodrine Hcl11$806
NitrofurantoinNitrofurantoin Macrocrystal29$770
Celecoxib27$765
Tamsulosin Hcl45$696
Losartan Potassium115$678
Calcitriol47$638
Metolazone39$607
Chlorthalidone18$474

Paid to pharmacies, not to this prescriber.

Other nephrology in Springdale

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →